119 related articles for article (PubMed ID: 23683422)
21. Immunoreactivity of B-cell markers (CD79a, L26) in rare cases of extranodal cytotoxic peripheral T- (NK/T-) cell lymphomas.
Blakolmer K; Vesely M; Kummer JA; Jurecka W; Mannhalter C; Chott A
Mod Pathol; 2000 Jul; 13(7):766-72. PubMed ID: 10912936
[TBL] [Abstract][Full Text] [Related]
22. A double-positive CD4+CD8+ T-cell population is commonly found in nodular lymphocyte predominant Hodgkin lymphoma.
Rahemtullah A; Reichard KK; Preffer FI; Harris NL; Hasserjian RP
Am J Clin Pathol; 2006 Nov; 126(5):805-14. PubMed ID: 17050078
[TBL] [Abstract][Full Text] [Related]
23. Intravascular T-cell lymphoma: A rare, poorly characterized entity with cytotoxic phenotype.
Sharma TL; Yeaney GA; Soltanzadeh P; Li Y; Cotta CV
Neuropathology; 2017 Aug; 37(4):365-370. PubMed ID: 28317291
[TBL] [Abstract][Full Text] [Related]
24. Primary cutaneous aggressive epidermotropic CD4/CD8 double-negative cytotoxic T-cell lymphoma.
Akkari H; Belhadjali H; Moussa A; Youssef M; Zili J
Pathologica; 2012 Apr; 104(2):78-81. PubMed ID: 22953504
[TBL] [Abstract][Full Text] [Related]
25. CD20-positive T-cell lymphoma with indolent clinical behaviour.
Xiao WB; Wang ZM; Wang LJ
J Int Med Res; 2010; 38(3):1170-4. PubMed ID: 20819457
[TBL] [Abstract][Full Text] [Related]
26. ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC).
Chikatsu N; Kojima H; Suzukawa K; Shinagawa A; Nagasawa T; Ozawa H; Yamashita Y; Mori N
Mod Pathol; 2003 Aug; 16(8):828-32. PubMed ID: 12920229
[TBL] [Abstract][Full Text] [Related]
27. CD8-positive primary cutaneous anaplastic large T-cell lymphoma (PCALCL): case report and review of this unusual variant of PCALCL.
Plaza JA; Ortega P; Lynott J; Mullane M; Kroft S; Olteanu H
Am J Dermatopathol; 2010 Jul; 32(5):489-91. PubMed ID: 20442639
[TBL] [Abstract][Full Text] [Related]
28. Immunophenotyping of mature T/NK cell neoplasm presenting as leukemia.
Gujral S; Polampalli S; Badrinath Y; Kumar A; Subramanian PG; Nair R; Sengar M; Nair C
Indian J Cancer; 2010; 47(2):189-93. PubMed ID: 20448385
[TBL] [Abstract][Full Text] [Related]
29. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
[TBL] [Abstract][Full Text] [Related]
30. Pagetoid reticulosis with CD30 positivity and cytotoxic/suppressor cells.
Jacyk WK; Grayson W; Dinkel JE; Requena L
J Cutan Pathol; 2007 Aug; 34(8):644-7. PubMed ID: 17640236
[TBL] [Abstract][Full Text] [Related]
31. Aggressive Lennert's lymphoma: report of three cases in comparison to non-aggressive Lennert's lymphoma.
Kitamura A; Yamashita Y; Sato Y; Hasegawa Y; Kojima H; Nagasawa T; Mori N
Pathol Int; 2005 Oct; 55(10):626-31. PubMed ID: 16185292
[TBL] [Abstract][Full Text] [Related]
32. Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology.
Chott A; Haedicke W; Mosberger I; Födinger M; Winkler K; Mannhalter C; Müller-Hermelink HK
Am J Pathol; 1998 Nov; 153(5):1483-90. PubMed ID: 9811340
[TBL] [Abstract][Full Text] [Related]
33. Subcutaneous Panniculitis-Like T-Cell Lymphoma in Children: A Review of the Literature.
Hu ZL; Sang H; Deng L; Li Z
Pediatr Dermatol; 2015; 32(4):526-32. PubMed ID: 25727090
[TBL] [Abstract][Full Text] [Related]
34. Primary central nervous system cytotoxic/suppressor T-cell lymphoma: report of a unique case and review of the literature.
Liu D; Schelper RL; Carter DA; Poiesz BJ; Shrimpton AE; Frankel BM; Hutchison RE
Am J Surg Pathol; 2003 May; 27(5):682-8. PubMed ID: 12717253
[TBL] [Abstract][Full Text] [Related]
35. Primary colorectal T-cell lymphoma.
Okada M; Maeda K; Suzumiya J; Hagimoto T; Wakamatsu S; Ohshima K; Kanda M; Sonoda T; Sakamoto A; Tamura K
J Gastroenterol; 2003; 38(4):376-84. PubMed ID: 12743779
[TBL] [Abstract][Full Text] [Related]
36. Primary hepatic Epstein-Barr virus-associated CD30-positive peripheral T-cell lymphoma of cytotoxic phenotype.
Peng Y; Cai J; Yue C; Qing X
Exp Mol Pathol; 2016 Feb; 100(1):207-11. PubMed ID: 26778690
[TBL] [Abstract][Full Text] [Related]
37. CD8+ epidermotropic cytotoxic T-cell lymphoma with peripheral blood and central nervous system involvement.
Introcaso CE; Kim EJ; Gardner J; Junkins-Hopkins JM; Vittorio CC; Rook AH
Arch Dermatol; 2008 Aug; 144(8):1027-9. PubMed ID: 18711076
[TBL] [Abstract][Full Text] [Related]
38. CD20-positive T-cell large granular lymphocyte leukemia: case report and review of the literature.
Miyazaki K; Ohsaka M; Suzuki Y; Danbara M; Horie R; Higashihara M
Intern Med; 2009; 48(16):1443-7. PubMed ID: 19687595
[TBL] [Abstract][Full Text] [Related]
39. [Clinicopathologic features and differential diagnosis of splenic B-cell marginal zone lymphoma involving bone marrow].
Sun Q; Zhang PH; Liu EB; Liu W; Li ZQ; Yang QY; Fang LH; Sun FJ; Chen HS; Qiu LG
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):234-8. PubMed ID: 23928529
[TBL] [Abstract][Full Text] [Related]
40. CD8+ T cells in cutaneous T-cell lymphoma: expression of cytotoxic proteins, Fas Ligand, and killing inhibitory receptors and their relationship with clinical behavior.
Vermeer MH; van Doorn R; Dukers D; Bekkenk MW; Meijer CJ; Willemze R
J Clin Oncol; 2001 Dec; 19(23):4322-9. PubMed ID: 11731515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
